Abstract

Sensitization Therapy for Warts

Author(s): Kuntz Rachael

Issue: Jul/Aug 2003 - After the Women's Health Initiative Trial

Page(s): 266-270

Download in electronic PDF format for $75

Abstract

This discussion of warts focuses on treatment (topical treatment, cryosurgery, laser therapy and electrotherapy), immunotherapy, (dinitrochlorobenzene, diphencyprone and squaric acid dibutylester) and applications in compounding. Tables provide information as to major wart classifications and their descriptions, topical agents used in the treatment of warts, formulations for sensitization therapy for warts (Dinitrochlorobenzene 0.5% to 2.0% in Acetone, Dinitrochlorobenzene 0.1% to 1% in Hydrophilic Petrolatum, Diphenylcyclopropenone 0.01% in Acetone, and Squaric Acid Dibutyl Ester 0.03% in Acetone) and Formulations for Topical Treatment of Warts (Cantharidin 0.7% Topical, Fluorouracil 5% Gel, Podophyllum 25% in Compound Tincture of Benzoin, Podophyllum 1% and Salicylic Acid 3% in Flexible Collodion, and Salicylic Acid 40% Ointment). The author concludes immunotherapy with agents such as those discussed in this article offers an alternative to traditional treatments that can take months to work or be painful. Since dinitrochlorobenzene is mutagenic, the author recommends only the other two immunotherapeutic agents for use; although studies proving their safety and efficacy are limited, available evidence suggests that immunotherapy can cure warts in a timely manner and often with little pain or irritation.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
Mar/Apr 2004 Pg. 126-129	Basics of Compounding for the Treatment of Warts Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 182-190	Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds Author(s): Touprong Robin, Thompson Tara, Williams LaVonn A
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Jul/Aug 2004 Pg. 275	Warts: Facts and Therapy (Patient Handout) Author(s): Kuntz Rachael
May/Jun 2003 Pg. 170-174	Five Compounds for Treating Diabetes-Related Conditions Author(s): Meece Jerry
May/Jun 2002 Pg. 207	Podophyllum, Lactic Acid, and Salicylic Acid Wart Mixture Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 426-435 View Sample	Sore Nipples in Breastfeeding Mothers: Causes and Treatments Author(s): Albright Lisa M
Mar/Apr 2002 Pg. 135	Wart Remover Mixture Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 460-463 View Sample	Basics of Compounding for Dry-Skin Conditions Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 176-178	Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer Author(s): Israel Alan
May/Jun 2002 Pg. 171-176	Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease Author(s): Osburn Jennifer
Sep/Oct 2015 Pg. 410	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 490-494	Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations Author(s): Branvold Andrea, Barner Jamie C
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Sep/Oct 2006 Pg. 324-328	Topical Cidofovir for Treatment of Resistant Viral Infections Author(s): McElhiney Linda F
May/Jun 2011 Pg. 204-213	Treatment Options for Psoriasis Author(s): Williams LaVonn A, Humphreys Erica
Jul/Aug 2011 Pg. 316-319	Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Author(s): Bramwell Bethany
Nov/Dec 2018 Pg. 446-454	Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Author(s): Zur Eyal
Jul/Aug 1999 Pg. 309-310	Acidifying Agents, Featured Excipient: Author(s): Allen Loyd V Jr